Calamos Advisors LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$10,097,100
-15.1%
7,500,0000.0%0.05%
-12.5%
Q4 2022$11,887,050
+11.9%
7,500,0000.0%0.06%
+14.3%
Q3 2022$10,626,000
+6.7%
7,500,0000.0%0.05%
+14.0%
Q2 2022$9,955,000
+1.9%
7,500,0000.0%0.04%
+16.2%
Q1 2022$9,765,000
+3.3%
7,500,0000.0%0.04%
+5.7%
Q4 2021$9,449,000
-5.8%
7,500,0000.0%0.04%
-20.5%
Q3 2021$10,031,000
+0.6%
7,500,0000.0%0.04%
-4.3%
Q2 2021$9,967,000
-1.7%
7,500,0000.0%0.05%
-16.4%
Q1 2021$10,139,000
-65.8%
7,500,000
-64.7%
0.06%
-68.0%
Q4 2020$29,654,000
+1.0%
21,268,0000.0%0.17%
-9.0%
Q3 2020$29,371,000
-16.8%
21,268,0000.0%0.19%
-24.1%
Q2 2020$35,286,000
+5.4%
21,268,000
-18.6%
0.25%
-5.3%
Q1 2020$33,463,000
-29.5%
26,136,000
-15.4%
0.26%
+11.9%
Q4 2019$47,492,000
+12.0%
30,906,0000.0%0.24%
+1.7%
Q3 2019$42,391,000
+3.7%
30,906,0000.0%0.23%
+1.8%
Q2 2019$40,865,000
+25.1%
30,906,000
+28.2%
0.23%
+11.3%
Q1 2019$32,660,000
+15.3%
24,105,000
+0.0%
0.20%
+9.1%
Q4 2018$28,333,000
-31.6%
24,100,0000.0%0.19%
-18.0%
Q3 2018$41,405,000
+57.7%
24,100,000
+33.1%
0.23%
+42.5%
Q2 2018$26,259,00018,100,0000.16%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Aequim Alternative Investments LP 24,000,000$30,877,0005.11%
Alken Asset Management Ltd 360,000$457,0001.90%
III Capital Management 3,500,000$4,481,0001.64%
SHENKMAN CAPITAL MANAGEMENT INC 3,920,000$5,113,0000.76%
CSS LLC/IL 6,842,000$8,745,0000.69%
DeepCurrents Investment Group LLC 10,408,000$13,373,0000.65%
SSI INVESTMENT MANAGEMENT LLC 4,334,000$5,554,0000.49%
WOLVERINE ASSET MANAGEMENT LLC 18,250,000$23,476,0000.34%
MACKAY SHIELDS LLC 24,612,000$31,641,0000.29%
Nicholas Investment Partners, LP 1,115,000$1,429,0000.28%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders